Barinthus Biotherapeutics plc (NASDAQ: BRNS)
$1.55
N/A ( 0% ) 3.4K
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
Market Data
Open
$1.55
Previous close
$1.55
Volume
3.4K
Market cap
$60.50M
Day range
$1.51 - $1.55
52 week range
$1.21 - $5.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 3 | Insider transactions | 2 | Jun 18, 2024 |
| 8-k | 8K-related | 14 | Jun 12, 2024 |
| 8-k | 8K-related | 57 | Jun 06, 2024 |
| 8-k | 8K-related | 14 | May 15, 2024 |
| 4 | Insider transactions | 1 | May 14, 2024 |
| 4 | Insider transactions | 1 | May 14, 2024 |
| 4 | Insider transactions | 1 | May 14, 2024 |
| 8-k/a | 8K-related | 47 | May 14, 2024 |
| 4 | Insider transactions | 1 | May 14, 2024 |